Israel Englander’s Vanda Pharmaceuticals VNDA Stock Holding History

Israel Englander’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100,000	Closed	-$499K	–	6502
2025 Q3	$499K	Buy	+100,000	New	+$463K	﹤0.01%	5071
2019 Q1	–	Sell	-73,900	Closed	-$1.93M	–	4363
2018 Q4	$1.93M	Buy	73,900 +48,900	+196%	+$1.15M	﹤0.01%	2199
2018 Q3	$574K	Buy	+25,000	New	+$510K	﹤0.01%	3167
2013 Q4	–	Sell	-227,400	Closed	-$2.49M	–	3810
2013 Q3	$2.49M	Buy	227,400 +46,800	+26%	+$500K	0.01%	1548
2013 Q2	$1.46M	Buy	+180,600	New	+$1.22M	﹤0.01%	1767

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Israel Englander's VNDA Position: Q2 2026 in Review

Israel Englander reduced its Vanda Pharmaceuticals (VNDA) stake by 15% in Q2 2026, selling an estimated $1.82M and leaving 1,602,813 shares worth $9.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2298.

Israel Englander first reported a position in VNDA in Q2 2013 and has held it in 52 quarters since. The position peaked at $28M in Q3 2016. 171 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Israel Englander held 1,602,813 shares of Vanda Pharmaceuticals worth $9.81M as of Q2 2026.
Israel Englander sold 278,188 Vanda Pharmaceuticals shares in Q2 2026, an estimated $1.82M.
Vanda Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2298 holding.
Israel Englander first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Israel Englander's Vanda Pharmaceuticals position peaked at $28M in Q3 2016.
171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.